What I see going forward is Nader’s percentage share of

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps
627
What I see going forward is Nader’s percentage share of running the company diminishing over time. Nader said around a year ago that he has considered a slower personal roll in the company. Nader said that Dr. Kelly would hire all new employees and further the International Advisory Board. Dr. Kelly has done a wonderful job so far and hit it out of the park with his last few hires.

A great leader is a person that recognizes his weaknesses and hires people to overcome such weaknesses. If you interviewed CEO’s they would tell you that the best things they ever did was to hire the right people and that’s where their success comes from. No one can do it all. Our time as a company with many many employees to do all the needed tasks required to be a big pharmaceutical company is as close as our first approval and revenue. We will grow then for sure.

I would not like to change leadership of Cytodyn at this point in time. It could delay us years and lose the relationships we now share with the FDA. You may not believe that Nader has a great relationship with the FDA but I believe he does. He gives them their due respect and that goes a long way in any relationship. Nader is smart that way.

You can hate or blame Nader all you want. But he has got us this far at a minimal cost and minimal time compared to the averages of biotechs looking for drug approvals. This is the reason we are in the position we are currently. Close to approval. With a change of direction to Covid is and was a huge directional change. Most of and/if not all were NOT supportive of his change of direction.

Fact is we are most likely to get our first approval in Covid. Looks like a genius move now and he took heat for it. Nader has made great decisions in funding and been very respectful of dilution. Great leadership quality is a conservative approach financially. Nader has that. We should be thankful.

I will support a leader like Nader all day long for the above reasons. He has recognized his mistakes and made changes and that is huge also. Nader has all the qualities we need to get us over the finish line. A lot of the items awaiting our finish are just out of our control and anyone’s control. No matter who is CEO. It’s up to the drug to prove itself out and for regulatory agencies to be aware of it. Nader will be there for us to smile and complement the FDA just like a great CEO would be there.

This is why he is the right person for the CEO of Cytodyn now and until he steps back further. There should be no doubt about that. Yet people will push their agenda and try to discredit Nader.

Listen to them and make your own opinion and review the facts about our CEO. I believe you will find far more important reasons to have Nader than to have someone else leading this company. over the finish line. But all opinions do matter. Do a proper pro/con assessment and have your own opinion.
2

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 94

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
Virax Biolabs Expands China Reach With Key Partnerships

Updated Category News Views 33

Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....

Continue Reading
LUNGevity's Every Breath Forward Drives Awareness and Action

Updated Category News Views 57

A Bold New Campaign for Lung Cancer Awareness Amidst the hustle and bustle of daily life, a solemn campaign rises, taking aim at lung cancer's staggering toll on lives. LUNGevity Foundation is rolling out its initiative, Every Breath Forward?, this November, spotlighting unity and action during Lung Cancer Awareness Month. Forget the red carpets and flashy...

Continue Reading
West Fraser Tackles Grim Quarter: Indefinite Mill Closures

Updated Category News Views 122

Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 0

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Navigating Homeowner Deductibles: Balancing Costs

Updated Category News Views 0

Understanding the Basics: Premiums and Deductibles Picture sorting through bills with a cup of lukewarm coffee, wondering if there’s a smarter way to handle homeowner insurance. Chuck Montgomery cuts through the fluff, talking turkey about balancing insurance dollars. One part of the game is deciding your deductible, the sum you fork over before insurance steps in...

Continue Reading
North Island Credit Union Eases Student Access to Banking

Updated Category News Views 210

Breaking Down Barriers with Student Banking Services Stumble into any financial setup these days, and you'll hear the same refrain: young people need more access to banking. North Island Credit Union seems to have taken that idea to heart, landing a national Bank On certification for their Student Checking account. It ain't just any badge; it's the mark of reliability,...

Continue Reading
A2Gold Divests Bolo in Strategic $1.5 Million Sale

Updated Category News Views 17

A2Gold Shifts Focus, Cashes in on Bolo You catch wind of A2Gold's latest move, and it's not just some footnote. This outfit's unloading its interest in the Bolo Gold Project over in Nye County, Nevada, to Super Gold Mining Corp. You'd think they're just getting rid of excess baggage, but there's more under the hood. Breakdown of the Deal The transaction's worth C$1.5...

Continue Reading
Mausam Bhatt Joins Cars.com as Chief Product Officer

Updated Category News Views 21

Shifting Gears with a New Leader Sometimes the name alone isn't enough to get things rolling, but when someone who's built billion-dollar platforms from scratch joins your team, the engine's ready to roar. That's the motor firing up at Cars.com with Mausam Bhatt behind the wheel as their fresh Chief Product Officer. If you think a new set of eyes can only see what's...

Continue Reading
Lilly Taps AI for Alzheimer’s Research with SpeechDx

Updated Category News Views 126

Some folks might just brush off a little forgetfulness as old age, but what if we could pinpoint Alzheimer's up front with just the way someone talks? That’s the big league play Eli Lilly's making by licensing the SpeechDx dataset from the Alzheimer's Drug Discovery Foundation (ADDF). This ain't your run-of-the-mill data—it's the largest harmonized longitudinal...

Continue Reading

Top 5 Most Recently Viewed Articles

Hafnia Limited Announces Third Quarter Dividend Details

Updated Category News Views 100

Key Information on Hafnia Limited's Third Quarter Dividend Hafnia Limited, a standout name in the shipping industry, has recently disclosed important information concerning its dividend for the third quarter of 2024. The news follows an announcement that the Company made regarding its financial performance and upcoming dividend payments. This announcement underscores...

Continue Reading
Epsium Enterprise Limited Reports Positive Interim Financials

Updated Category News Views 186

Epsium Enterprise Limited Announces Financial Performance Epsium Enterprise Limited (NASDAQ: EPSM) has unveiled its unaudited financial results for the six-month period ended June 30, 2025, reflecting a committed approach to growth and fiscal responsibility. As a notable importer and distributor of premium alcoholic beverages, the company's robust financial foundation...

Continue Reading
Infosys Partners with LTA to Transform Tennis Experiences

Updated Category News Views 210

Infosys and LTA Forge a Historic Partnership Infosys has entered into a strategic multi-year partnership with the Lawn Tennis Association (LTA) to revolutionize the HSBC Championships held at the renowned Queen's Club in London. This collaboration marks a significant step forward in the intersection of technology and sports, enhancing the fan experience and elevating...

Continue Reading
Kairos Pharma's Upcoming Engagement at the Maxim Healthcare Summit

Updated Category News Views 112

Engaging Insights from Kairos Pharma at Maxim Healthcare Summit LOS ANGELES – Kairos Pharma Ltd. (NYSE American: KAPA), a prominent clinical-stage biopharmaceutical company, is excited to announce an engaging opportunity at the upcoming Maxim Healthcare Virtual Summit. This virtual event is set to provide crucial insights into the latest developments in the healthcare...

Continue Reading
GCM Grosvenor Showcases Impressive Q3 2024 Financial Growth

Updated Category News Views 77

Positive Financial Results for GCM Grosvenor GCM Grosvenor, a respected name in alternative asset management, has reported remarkable earnings results for the third quarter of 2024. This global asset management firm has seen year-to-date fundraising surge by 34%, which is a testament to its robust business model and strong market positioning. Furthermore, key financial...

Continue Reading